http://www.reportlinker.com/ci02244/General-Medicine-and-Specialty-Medicine.html Fri, 24 May 2013 19:17:45 +0000 helpdesk@reportlinker.com Copyright 2013, Reportlinker Zend_Feed en-us http://blogs.law.harvard.edu/tech/rss http://www.reportlinker.com/d014234955/The-United-States-Country-Outlook-2013-focus-on-General-Medicine-and-Specialty-Medicine.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public http://www.reportlinker.com/d014234955/The-United-States-Country-Outlook-2013-focus-on-General-Medicine-and-Specialty-Medicine.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public ]]> Sun, 31 Mar 2013 22:00:00 +0000 http://www.reportlinker.com/d014356929/Company-Report-Regenerative-Medicine-in-The-United-States-for-Year-2013.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public http://www.reportlinker.com/d014356929/Company-Report-Regenerative-Medicine-in-The-United-States-for-Year-2013.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public ... Of peripheral nerve repair solutions. The company S innovative approach to regenerative medicine has resulted in first-in- class products that will define their product categories. Axogen S products offer a full ...]]> Tue, 30 Apr 2013 22:00:00 +0000 http://www.reportlinker.com/d014352147/Company-Report-General-Medicine-and-Specialty-Medicine-for-Year-2013.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public http://www.reportlinker.com/d014352147/Company-Report-General-Medicine-and-Specialty-Medicine-for-Year-2013.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public ... Experience; increase capture of inpatients through ed and local primary care physicians -strengthen services for vascular surgery and ob programs -reduce outmigration and improve in-migration -further ...]]> Sun, 31 Mar 2013 22:00:00 +0000 http://www.reportlinker.com/d014350688/Company-Report-General-Medicine-and-Specialty-Medicine-for-Year-2013.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public http://www.reportlinker.com/d014350688/Company-Report-General-Medicine-and-Specialty-Medicine-for-Year-2013.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public ]]> Sun, 31 Mar 2013 22:00:00 +0000 http://www.reportlinker.com/d014330011/The-Russian-General-Medicine-and-Specialty-Medicine-Business-Brief.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public http://www.reportlinker.com/d014330011/The-Russian-General-Medicine-and-Specialty-Medicine-Business-Brief.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public ... Yen astellas Our business model in global 4 urology transplantation oncology current gcl Neuroscience Dm complications & kidney diseases Immunology & infectious diseases third ...]]> Sun, 31 Mar 2013 22:00:00 +0000 http://www.reportlinker.com/d014322823/General-Medicine-and-Specialty-Medicine-Business.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public http://www.reportlinker.com/d014322823/General-Medicine-and-Specialty-Medicine-Business.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public ... Scientist; radiotherapy physicist clinical vascular scientist; respiratory physiologist; sleep physiologist. Consultants in: haematology; emergency medicine; old age psychiatry.. Non-consultant, non ...]]> Sun, 31 Mar 2013 22:00:00 +0000 http://www.reportlinker.com/d014238077/U-S-General-Medicine-and-Specialty-Medicine-Industry.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public http://www.reportlinker.com/d014238077/U-S-General-Medicine-and-Specialty-Medicine-Industry.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public ]]> Sun, 31 Mar 2013 22:00:00 +0000 http://www.reportlinker.com/d014234957/The-Canadian-General-Medicine-and-Specialty-Medicine-Business.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public http://www.reportlinker.com/d014234957/The-Canadian-General-Medicine-and-Specialty-Medicine-Business.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public ... Colleges, public/private schools) career opportunities many graduates with bmsc degrees go on to pursue further education in professional schools such as: dentistry medicine veterinary medicine pharmacy ...]]> Sun, 31 Mar 2013 22:00:00 +0000 http://www.reportlinker.com/d014266221/General-Surgery-Sector-Analysis-in-The-United-States.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public http://www.reportlinker.com/d014266221/General-Surgery-Sector-Analysis-in-The-United-States.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public ... For primary care physicians Increasing costs related to sustaining associated services (technology, facilities, and people) a few financial issues Poor surgical reimbursement continues to prevail ...]]> Sun, 31 Mar 2013 22:00:00 +0000 http://www.reportlinker.com/d014314804/Vascular-Surgery-Market-in-The-United-Kingdom.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public http://www.reportlinker.com/d014314804/Vascular-Surgery-Market-in-The-United-Kingdom.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_public ... Advancement Requirement for multi-disciplinary working Evolution of vascular surgery as a monospeciality Provision of contemporary emergency services vascular surgery and contemporary ...]]> Sun, 31 Mar 2013 22:00:00 +0000 http://www.reportlinker.com/p01163176/EpiCast-Report-Idiopathic-Pulmonary-Fibrosis-Epidemiology-Forecast-to.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_premium http://www.reportlinker.com/p01163176/EpiCast-Report-Idiopathic-Pulmonary-Fibrosis-Epidemiology-Forecast-to.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_premium EpiCast Report: Idiopathic Pulmonary Fibrosis - Epidemiology Forecast to 2022 Summary Idiopathic pulmonary fibrosis (IPF) is a chronic, fibrosing interstitial pneumonia of unknown cause that occurs primarily ...]]> Thu, 11 Apr 2013 22:00:00 +0000 http://www.reportlinker.com/p01158450/EpiCast-Report-Postmenopausal-Vaginal-Atrophy-Epidemiology-Forecast-to.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_premium http://www.reportlinker.com/p01158450/EpiCast-Report-Postmenopausal-Vaginal-Atrophy-Epidemiology-Forecast-to.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_premium EpiCast Report: Postmenopausal Vaginal Atrophy - Epidemiology Forecast to 2022 Summary The urogenital tract, specifically the vagina, urethra, bladder, trigone of the bladder, and pelvic floor muscles, ...]]> Sat, 30 Mar 2013 23:00:00 +0000 http://www.reportlinker.com/p0284895/Analytical-Tool-Apoptosis-in-Oncology.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_premium http://www.reportlinker.com/p0284895/Analytical-Tool-Apoptosis-in-Oncology.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_premium "Analytical Tool - Apoptosis in Oncology" offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in apoptotic drug development for the treatment of cancer. It is ...]]> Sun, 21 Apr 2013 22:00:00 +0000 http://www.reportlinker.com/p0284896/Analytical-Tool-Angiogenesis-in-Oncology.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_premium http://www.reportlinker.com/p0284896/Analytical-Tool-Angiogenesis-in-Oncology.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_premium "Analytical Tool - Angiogenesis in Oncology" offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in anti-angiogenic drug development for the treatment of cancer. ...]]> Sun, 21 Apr 2013 22:00:00 +0000 http://www.reportlinker.com/p0379863/Analytical-Tool-Peptides-in-Oncology.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_premium http://www.reportlinker.com/p0379863/Analytical-Tool-Peptides-in-Oncology.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_premium "Analytical Tool- Peptides in Oncology" offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in peptide drug development for the treatment of cancer. It is at ...]]> Sun, 21 Apr 2013 22:00:00 +0000 http://www.reportlinker.com/p01158533/Pharmaceutical-Healthcare-Annual-Deals-Analysis-M-A-and-Investments-Trends.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_premium http://www.reportlinker.com/p01158533/Pharmaceutical-Healthcare-Annual-Deals-Analysis-M-A-and-Investments-Trends.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_premium Pharmaceutical & Healthcare Annual Deals Analysis: M&A and Investments Trends - 2012 Summary GlobalData's ?Pharmaceutical & Healthcare Annual Deals Analysis: M&A and Investments Trends - 2012? report ...]]> Sat, 30 Mar 2013 23:00:00 +0000 http://www.reportlinker.com/p01190424/Synagis-Pediatric-RSV-Forecast-and-Market-Analysis-to.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_premium http://www.reportlinker.com/p01190424/Synagis-Pediatric-RSV-Forecast-and-Market-Analysis-to.html?utm_source=distribution#utm_campaign=distribution_kidela#utm_medium=distribution_premium Synagis (Pediatric RSV) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, ?Synagis (Pediatric RSV) - Forecast and Market Analysis to 2022?. ...]]> Mon, 29 Apr 2013 22:00:00 +0000